
Popular HIV Drug Linked to Higher Risk for MACE
TOPLINE: Among patients with HIV with low-to-moderate cardiovascular risk, both former and current exposure to abacavir was associated with an increased risk for major adverse cardiovascular events (MACE) compared with nonexposure. METHODOLOGY: Researchers …